Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorAydin, S.
dc.contributor.authorOzoner, B.
dc.contributor.authorSahin, S.
dc.contributor.authorAlizada, O.
dc.contributor.authorComunoglu, N.
dc.contributor.authorOz, B.
dc.contributor.authorTanriover, N.
dc.date.accessioned2020-12-02T18:00:09Z
dc.date.available2020-12-02T18:00:09Z
dc.date.issued2020
dc.identifier.issn0303-8467
dc.identifier.urihttps://doi.org/10.1016/j.clineuro.2020.106201
dc.identifier.urihttp://hdl.handle.net/11446/3542
dc.descriptionPubMed: 32927330en_US
dc.description.abstractObjective: A thorough follow-up study in which the same clinic presents the change in the surgical outcomes of acromegaly over the years, is still lacking in the endoscopic era. in this study, we intended to evaluate the clinical characteristics, radiological features, surgical and late remission rates of newly diagnosed acromegaly patients treated in our clinic between 2014 and 2019 in order to delineate the surgical remission status according to radiological, microscopic, and hormonal features. As a follow-up to our initial report, we also aimed to display the change of surgical remission rates over time in a tertiary center. Methods: A total of newly diagnosed 106 patients with acromegaly, who underwent endoscopic endonasal trans-sphenoidal approach (EETSA) in the last five years were retrospectively analyzed and presented in this study. Medical records were reviewed in clinical, biochemical, pathological, and radiological aspects to assess the relationship of preoperative patient characteristics with surgical remissions. Results: the percentages of the giant pituitary adenomas (?4 cm), adenomas with suprasellar extension and adenomas with surgically proven invasion of the cavernous sinus in the present series were 13%, 34%, and 20%, respectively. Gross total resection was achieved in 80% of the patients. Surgical remission and late remission rates were 66% and 86%, respectively. Nine (9.4%) patients in our current report had postoperative transient diabetes insipidus. the mean follow-up period in this series was 36.1 ± 18.1 (range 12–59) months. Conclusion: the presented surgical results are considerably better than our published initial series of acromegaly patients operated in the same clinic between 2007 and 2014. the improvement in surgical remission rate support a positive surgical volume - remission rate relationship for acromegaly in the era of endoscopic endonasal skull base approaches. One possible factor for better results may be the increasing surgical experience in EETSA, which follows a trend toward gradual improvement of long-term late remissions via a multidisciplinary approach. © 2020 Elsevier B.V.en_US
dc.description.sponsorshipThe authors would like to thank Esra Gungormus, Registered Nurse (RN) in Cerrahpasa Pituitary Center, for providing pre- and postoperative critical care to our patients with pituitary pathologies.en_US
dc.language.isoengen_US
dc.publisherElsevier B.V.en_US
dc.identifier.doi10.1016/j.clineuro.2020.106201en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAcromegalyen_US
dc.subjectEndoscopyen_US
dc.subjectPituitary adenomaen_US
dc.subjectRemissionen_US
dc.subjectTranssphenoidal surgeryen_US
dc.titleA follow-up study on outcomes of endoscopic transsphenoidal approach for acromegalyen_US
dc.typearticleen_US
dc.relation.journalClinical Neurology and Neurosurgeryen_US
dc.departmentDBÜen_US
dc.identifier.volume198en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-tempAydin, S., Department of Neurosurgery, Okmeydani Training and Research Hospital, University of Health Sciences, Istanbul, Turkey; Ozoner, B., Department of Neurosurgery, Bahcesehir University Faculty of Medicine, Istanbul, Turkey; Sahin, S., Department of Endocrinology and Metabolism, Cerrahpasa Medical Faculty, Istanbul University – Cerrahpasa, Istanbul, Turkey; Alizada, O., Department of Neurosurgery, Cerrahpasa Medical Faculty, Istanbul University – Cerrahpasa, Istanbul, Turkey; Comunoglu, N., Department of Pathology, Cerrahpasa Medical Faculty, Istanbul University – Cerrahpasa, Istanbul, Turkey; Oz, B., Department of Pathology, Cerrahpasa Medical Faculty, Istanbul University – Cerrahpasa, Istanbul, Turkey; Gazioglu, N., Department of Neurosurgery, Demiroglu Bilim University Schoolen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster